Skip to contentI
iBio, Inc.
I
IBIOiBio, Inc. Q1 2014 · 10-Q
Revenue$0.00$0.00−100.0% vs Q1 2013 Net Income$379.00K$379.00KN/M vs Q1 2013 EPS Diluted$0.01$0.01N/M vs Q1 2013 Operating Income$240,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
Free Cash Flowderived-$911,000— ended Sep 30, 2013 · filed Nov 14, 2013 · 45 d after period end